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LETTERS TO THE EDITOR
Protein diet and hypercalciuria
To the Editor: In an interesting study in a recent issue of
Kidney International, Amanzadeh et al [1] reported that
a high animal protein diet in rats decreased urinary pH
and citrate excretion, and increased urinary calcium and
phosphate excretion and bone resorption. The authors
concluded that both the kidney and bone contributed to
the pathogenesis of hypercalciuria during animal protein
excess.
In light of our recent studies, we would like to propose
another mechanism to explain the origin of hypercalci-
uria by animal protein ingestion. The increased risk for
stone formation by high protein intake could be caused by
its effects on membrane phospholipid fatty acid compo-
sition, in particular, phospholipid arachidonic acid (AA)
level, which plays a crucial role in the pathogenesis of
hypercalciuria [2–4].
In fact, a modification in phospholipid AA levels by
dietary protein manipulation of delta-6-desaturase, the
rate-limiting step of the biosynthetic pathway of highly
unsaturated fatty acids, determines in animals and hu-
mans a cascade of metabolic effects on intestinal, re-
nal, and bone calcium transport and metabolism, lead-
ing to hypercalciuria. It has been demonstrated that AA
can influence urinary calcium excretion directly or indi-
rectly through the PGE2/1,25 (OH)2 vitamin D pathway
or bone cytokine synthesis [2–4].
A model constructed using the path analysis technique
suggests that bone loss in idiopathic hypercalciuric pa-
tients is a consequence of the negative calcium balance
related to AA-associated high bone turnover and PGE2-
induced hypercalciuria, in spite of increased intestinal cal-
cium absorption (unpublished data).
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Reply from the Author
We thank Dr. Baggio for his comments on our
manuscript, and the generous sharing of his thoughts and
unpublished data with the readers of Kidney Interna-
tional. Our intention was to establish an animal model
that reproduces the human condition of protein-induced
hypercalciuria and bone loss to allow further pathophysi-
ologic studies. The published body of data currently does
not favor any one particular mechanism of hypercal-
ciuria, and most certainly does not exclude the phos-
pholipid paradigm. In addition to the correlative stud-
ies done in cultured cells and surrogate tissues such as
erythrocytes, we will be most delighted and the whole
stone field will reap benefit if Dr. Baggio’s group can use
this animal model to definitively prove the phospholipid
hypothesis.
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Has the time come for new
diagnostic criteria of Balkan
endemic nephropathy?
To the Editor: In a recent issue of Kidney International
[1], inflammatory process, estimated by urine neopterin
concentration, erythrocyte sedimentation rate (ESR),
and hemoglobin concentrations have been suggested to
be involved in the pathophysiology of Balkan endemic
nephropathy (BEN). As the authors claimed, BEN re-
mains a disease with uncertain etiology.
Pathophysiologic studies in BEN, although rare,
showed a non-inflammatory pattern of interstitial fibro-
sis, tubular atrophy, and an absence of significant cellular
infiltration even in early stages of disease [2, 3].
Criteria for BEN diagnosis in this study were mainly
based on family history of kidney disease or chronic re-
nal failure (CRF). These diagnostic criteria were almost
half a century old, but are still in use [4]. The authors
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have not provided diagnostic criteria for one third of the
patients, whose average serum creatinine concentrations
were similar to those in patients with a family history
(118.06 ± 28.62 vs. 130.23 ± 15.47, P = .103). Even the
diagnostic criteria for patient enrollment in this study are
acceptable; three of them had the possibility for pathohis-
tologic confirmation of BEN in tissue unaffected by renal
tumor.
The conclusion reached by the authors was that the
triad of higher urinary neopterin (found in 50% of
patients), erythrocyte sedimentation rate (ESR), and
anemia, frequently seen in patients with infectious or ma-
lignant diseases, was absent in patients with BEN.
It is difficult to perform research aimed at explain-
ing pathophysiologic events in BEN without clear diag-
nostic criteria, especially before CRF onset. Results of
Toncheva et al confirmed a non-inflammatory nature of
BEN, but suggested that the time for revision of diagnos-
tic criteria of BEN has come.
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Reply from the Authors
We would like to inform the readers that biological
materials for neopterin study were collected from BEN
patients who had been managed in dispancery during
a long period of time (25–30 years). All patients in the
published study [1] fulfilled the present criteria for BEN,
and the diagnosis was confirmed histomorphologically,
as well. Therefore, there is no doubt about the diagnostic
parameters used to recruit the patient group.
With regard to the revision of BEN diagnostic criteria,
we consider that all criteria [2–4], used for 50 years, cannot
be neglected. The time showed that they take place in
BEN diagnostics. The diagnostic complex of the disease
could only be enriched by new scientific results.
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Tubulointerstitial injury: Early
or late event in the
pathogenesis of hypertensive
nephropathy?
To the Editor: In Supplement 86 of Kidney Interna-
tional, Sanchez-Lozanda et al [1] elegantly overviewed
the complex relationships between arteriolopathy, tubu-
lointerstitial inflammation, and glomerular hemody-
namics in different models of chronic kidney disease.
Unfortunately, the pathogenesis of kidney injury related
to primary hypertension was barely discussed and re-
quires completion. From the traditional point of view,
the initial sites of kidney damage are medium- and small-
sized arteries presenting myointimal and media hypertro-
phy, hyaline degeneration, and sclerosis [2]. Arteriolopa-
thy leads to the transmission of systemic hypertension to
glomerular capillaries and glomerulosclerosis, otherwise
it may result in ischemia of further nephron structures,
leading to tubular atrophy and interstitial fibrosis. Some
investigators, however, challenge this paradigm, suggest-
ing that it is the tubules and interstitium, rather, that
constitute the initial site of kidney injury. In two-kidney
one-clip rats, Mai et al [3] demonstrated that interstitial
injury occurs early, before glomerular changes become
evident. In hypertensive rats, others observed increased
lipid peroxidation in the renal tubules, but not in the vas-
cular compartment, much earlier than proteinuria or loss
of renal function could be detected [4]. In this regard, we
have recently shown increased urine excretion of tubu-
lar damage markers in patients with untreated primary
hypertension without clinical signs of vascular and
